These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
313 related items for PubMed ID: 15659701
1. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Alwayn IP, Gura K, Nosé V, Zausche B, Javid P, Garza J, Verbesey J, Voss S, Ollero M, Andersson C, Bistrian B, Folkman J, Puder M. Pediatr Res; 2005 Mar; 57(3):445-52. PubMed ID: 15659701 [Abstract] [Full Text] [Related]
2. The route of lipid administration affects parenteral nutrition-induced hepatic steatosis in a mouse model. Javid PJ, Greene AK, Garza J, Gura K, Alwayn IP, Voss S, Nose V, Satchi-Fainaro R, Zausche B, Mulkern RV, Jaksic T, Bistrian B, Folkman J, Puder M. J Pediatr Surg; 2005 Sep; 40(9):1446-53. PubMed ID: 16150347 [Abstract] [Full Text] [Related]
3. Prevention of reperfusion injury and microcirculatory failure in macrosteatotic mouse liver by omega-3 fatty acids. El-Badry AM, Moritz W, Contaldo C, Tian Y, Graf R, Clavien PA. Hepatology; 2007 Apr; 45(4):855-63. PubMed ID: 17393510 [Abstract] [Full Text] [Related]
4. Omega-3 fatty acids reduce hepatic steatosis and consequently attenuate ischemia-reperfusion injury following partial hepatectomy in rats. Marsman HA, Heger M, Kloek JJ, Nienhuis SL, ten Kate FJ, van Gulik TM. Dig Liver Dis; 2011 Dec; 43(12):984-90. PubMed ID: 21840275 [Abstract] [Full Text] [Related]
10. Chemical composition of hepatic lipids mediates reperfusion injury of the macrosteatotic mouse liver through thromboxane A(2). El-Badry AM, Jang JH, Elsherbiny A, Contaldo C, Tian Y, Raptis DA, Laczko E, Moritz W, Graf R, Clavien PA. J Hepatol; 2011 Dec; 55(6):1291-9. PubMed ID: 21703192 [Abstract] [Full Text] [Related]
11. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice. Arendash GW, Jensen MT, Salem N, Hussein N, Cracchiolo J, Dickson A, Leighty R, Potter H. Neuroscience; 2007 Oct 26; 149(2):286-302. PubMed ID: 17904756 [Abstract] [Full Text] [Related]
12. Hepatic regeneration and functional recovery following partial liver resection in an experimental model of hepatic steatosis treated with omega-3 fatty acids. Marsman HA, de Graaf W, Heger M, van Golen RF, Ten Kate FJ, Bennink R, van Gulik TM. Br J Surg; 2013 Apr 26; 100(5):674-83. PubMed ID: 23456631 [Abstract] [Full Text] [Related]
15. Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injury. Llacuna L, Fernández A, Montfort CV, Matías N, Martínez L, Caballero F, Rimola A, Elena M, Morales A, Fernández-Checa JC, García-Ruiz C. J Hepatol; 2011 May 26; 54(5):1002-10. PubMed ID: 21145825 [Abstract] [Full Text] [Related]
16. Dietary krill oil supplementation reduces hepatic steatosis, glycemia, and hypercholesterolemia in high-fat-fed mice. Tandy S, Chung RW, Wat E, Kamili A, Berge K, Griinari M, Cohn JS. J Agric Food Chem; 2009 Oct 14; 57(19):9339-45. PubMed ID: 19761211 [Abstract] [Full Text] [Related]
19. Reversal of high-fat diet-induced hepatic steatosis by n-3 LCPUFA: role of PPAR-α and SREBP-1c. Dossi CG, Tapia GS, Espinosa A, Videla LA, D'Espessailles A. J Nutr Biochem; 2014 Sep 14; 25(9):977-84. PubMed ID: 24993917 [Abstract] [Full Text] [Related]
20. Inhibition of matrix metalloproteinases increases PPAR-alpha and IL-6 and prevents dietary-induced hepatic steatosis and injury in a murine model. Alwayn IP, Andersson C, Lee S, Arsenault DA, Bistrian BR, Gura KM, Nose V, Zauscher B, Moses M, Puder M. Am J Physiol Gastrointest Liver Physiol; 2006 Dec 14; 291(6):G1011-9. PubMed ID: 16844679 [Abstract] [Full Text] [Related] Page: [Next] [New Search]